Cargando…

Evaluation of Adverse Events in Total Disc Replacement: A Meta-Analysis of FDA Summary of Safety and Effectiveness Data

STUDY DESIGN: Systematic review and meta-analysis. OBJECTIVES: The safety of new technology such as cervical total disc replacement (TDR) is of paramount importance and is best evaluated in randomized clinical trials (RCT). We compared complication risks of TDR to fusion using data from Investigatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Paul A., Nassr, Ahmad, Currier, Bradford L., Sebastian, Arjun S., Arnold, Paul M., Fehlings, Michael G., Mroz, Thomas E., Riew, K. Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400198/ https://www.ncbi.nlm.nih.gov/pubmed/28451497 http://dx.doi.org/10.1177/2192568216688195

Ejemplares similares

Perioperative Vision Loss in Cervical Spinal Surgery
por: Gabel, Brandon C., et al.
Publicado: (2017)

Iatrogenic Spinal Cord Injury Resulting From Cervical Spine Surgery
por: Daniels, Alan H., et al.
Publicado: (2017)

Cervical artificial disc replacement: still experimental? Introduction and perspectives on cervical artificial disc replacement
por: Chapman, Jens R., et al.
Publicado: (2012)

Thromboembolic Disease after Cervical Spine Surgery: A Review of 5,405 Surgical Procedures and Matched Cohort Analysis
por: Sebastian, Arjun S., et al.
Publicado: (2015)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

Comparison of 2-Level Versus 1-Level Total Disc Replacement: Results From a Prospective FDA-Regulated Trial
por: Zigler, Jack E., et al.
Publicado: (2008)

Adverse Events Following Cervical Disc Arthroplasty: A Systematic Review
por: Xu, Jordan C., et al.
Publicado: (2017)

Adverse Events in Total Ankle Arthroplasty, Analysis of the FDA Medical and User Facility Device Experience Database
por: Mahmoud, Karim, et al.
Publicado: (2019)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
por: Lao, Dong-Hui, et al.
Publicado: (2021)

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Total Disc Replacement in Lumbar Degenerative Disc Diseases
por: Park, Chun Kun
Publicado: (2015)

Total disc replacement in the cervical spine: a systematic review evaluating long-term safety
por: Anderson, Paul A., et al.
Publicado: (2012)

Kinematics of total facet replacement (TFAS-TL) with total disc replacement
por: Voronov, Leonard I., et al.
Publicado: (2009)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
por: Zou, Shu-peng, et al.
Publicado: (2023)

Bryan total disc arthroplasty: a replacement disc for cervical disc disease
por: Wenger, Markus, et al.
Publicado: (2010)

An Objective and Reliable Method for Identifying Sarcopenia in Lumbar Spine Surgery Patients: Using Morphometric Measurements on Computed Tomography Imaging
por: Tomov, Marko, et al.
Publicado: (2020)

The Mobi-C cervical disc for one-level and two-level cervical disc replacement: a review of the literature
por: Alvin, Matthew D, et al.
Publicado: (2014)

Risk Factors for Venous Thromboembolism following Thoracolumbar Surgery: Analysis of 43,777 Patients from the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2012
por: Sebastian, Arjun S., et al.
Publicado: (2016)

Osteopenia and Total Disc Prosthesis Subsidence: Inclusion/Exclusion Criteria for Total Disc Replacement
por: Lee, Casey K.
Publicado: (2007)

Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
por: Iarikov, Dmitri, et al.
Publicado: (2015)

Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
por: Fukuda, Akiho, et al.
Publicado: (2017)

Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
por: Jiao, Xue-feng, et al.
Publicado: (2020)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
por: Ding, Lingqing, et al.
Publicado: (2022)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2022)

Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2013)

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review
por: Macklis, Paul C., et al.
Publicado: (2020)

Misplaced Cervical Screws Requiring Reoperation
por: Peterson, Jeremy C., et al.
Publicado: (2017)

Hypoglossal Nerve Palsy After Cervical Spine Surgery
por: Ames, Christopher P., et al.
Publicado: (2017)

Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
por: Li, Ying, et al.
Publicado: (2020)

Material Science in Cervical Total Disc Replacement
por: Pham, Martin H., et al.
Publicado: (2015)

Clinical outcomes of two revision strategies for failed total disc replacements
por: Punt, Ilona, et al.
Publicado: (2012)

Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
por: Su, Si, et al.
Publicado: (2023)

The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment
por: Blumenthal, Scott L., et al.
Publicado: (2007)

A Multicenter Review of Superior Laryngeal Nerve Injury Following Anterior Cervical Spine Surgery
por: Tempel, Zachary J., et al.
Publicado: (2017)

Carfilzomib-induced Cardiotoxicity: An Analysis of the FDA Adverse Event Reporting System (FAERS)
por: Buck, Benjamin, et al.
Publicado: (2022)

Physical capability outcomes after total disc replacement with ProDisc-L
por: Sullivan, Humbert G., et al.
Publicado: (2012)

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
por: Huang, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mb98f2m1kuckkpmiks8hvddrch